SCHEMBL2013352

SCHEMBL2013352

O=CCc1cc(Cl)c2cccnc2c1N1CCC[C@H](O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 3/20 0.43
KCNMA1 Q12791 1/20 0.40
MAPT P10636 6/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
NPSR1 Q6W5P4 5/20 0.40
KDM4E B2RXH2 4/20 0.40
LMNA P02545 4/20 0.40
TDP1 Q9NUW8 4/20 0.40
RAB9A P51151 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
USP2 O75604 1/20 0.40
NOD2 Q9HC29 1/20 0.40
HTT P42858 5/20 0.39
ALDH1A1 P00352 3/20 0.39
MPI P34949 2/20 0.39
NPC1 O15118 3/20 0.39
SLC40A1 Q9NP59 2/20 0.39
HSP90AA1 P07900 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2017442 0.94 SLC40A1 (0.44) METAP2MAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL2015476 0.88 METAP2 (0.42) METAP2MAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL2014321 0.88 METAP2 (0.41) METAP2MAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL2015905 0.85 METAP2 (0.39) METAP2MAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL2014591 0.85 METAP2 (0.44) METAP2KCNMA1MAPTSMN1; SMN2NPSR1
SCHEMBL2014589 0.85 METAP2 (0.44) METAP2KCNMA1MAPTSMN1; SMN2NPSR1
SCHEMBL2018198 0.85 METAP2 (0.41) METAP2MAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL2013917 0.82 METAP2 (0.43) METAP2MAPTSMN1; SMN2NPSR1KDM4E
SCHEMBL2018360 0.82 SLC40A1 (0.36) METAP2KCNMA1MAPTKDM4ELMNA
SCHEMBL2015107 0.81 MAPT (0.39) METAP2MAPTSMN1; SMN2NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed